Extended interval gentamicin dosing in newborns
Part of Infections clinical trials.
This study looks at spacing out doses of the antibiotic gentamicin for newborns up to 7 days old who need it. The goal is to make sure the dosing schedule works well and is safe for babies.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Newborn baby up to 7 days old
- Baby is receiving the antibiotic gentamicin
- Doctors have measured the gentamicin levels in baby's blood after the third dose
- Baby got the correct dose for their weight (within 10% variation is okay)
- Baby does not have kidney problems from birth
- Baby is not taking other drugs that can harm the kidneys or ears during the first 3 days of gentamicin
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study aims to find the best dose of ampicillin for premature babies in the NICU who are being treated for possible early infection. The goal is to improve treatment and reduce side effects.
This trial is testing ways to make the best treatment decisions for newborns who may have an early infection (sepsis). It focuses on babies born at 34 weeks or later and within their first three days of life.
This study tests whether a local injection of gentamicin, an antibiotic, into the incision area can help prevent infections after a planned C-section. It may offer extra protection beyond standard antibiotics.
This trial tests a type of antibiotic called aminoglycosides to treat early sepsis (a serious infection). It is for adults in the hospital who are sick enough to need strong antibiotics but not in the worst stage of the illness.
This trial studies a better way to monitor and adjust vancomycin (an antibiotic) dosing in very young infants. It may help your baby get the right dose while reducing the risk of under- or over-dosing.
This study aims to find the best dose of the antibiotic colistin for premature babies (born before 37 weeks) in the neonatal intensive care unit who have a serious infection that is resistant to other antibiotics. The goal is to treat the infection effectively while reducing the risk of kidney damage.
Hear when a new Early Onset Sepsis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.